
CAS 353519-63-8
:Formula:C25H25N3O2
InChI:InChI=1S/C25H25N3O2/c1-4-30-21-13-11-19(15-16(21)2)23(28-22-7-5-6-14-26-22)20-12-10-18-9-8-17(3)27-24(18)25(20)29/h5-15,23,29H,4H2,1-3H3,(H,26,28)
InChI key:CYNZBLNMIJNBSF-UHFFFAOYSA-N
SMILES:CCOC1=C(C=C(C=C1)C(C2=C(C3=C(C=CC(=N3)C)C=C2)O)NC4=CC=CC=N4)C
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
HLM006474
CAS:HLM006474 is a pan inhibitor of E2F. This inhibits E2F4 DNA-binding (IC50: 29.8 μM in A375 cells).Formula:C25H25N3O2Purity:99.20% - 99.38%Color and Shape:SolidMolecular weight:399.48497-((4-Ethoxy-3-Methylphenyl)(2-Pyridylamino)Methyl)-2-Methyl-Quinolinol
CAS:7-((4-Ethoxy-3-Methylphenyl)(2-Pyridylamino)Methyl)-2-Methyl-QuinolinolFormula:C25H25N3O2Purity:>98%Molecular weight:399.48HLM006474
CAS:7-((4-Ethoxy-3-methylphenyl)(pyridin-2-ylamino)methyl)-2-methylquinolin-8-olFormula:C25H25N3O2Purity:98+%Molecular weight:399.48E2F Inhibitor, HLM006474
CAS:HLM006474 is a small molecule inhibitor of the E2F transcription factor. HLM006474 binds to the E2F protein and prevents it from binding to DNA, thereby inhibiting transcriptional regulation. This drug has been shown to be effective in animal models of cancer, hepatic steatosis, and diabetes. HLM006474 also inhibits CDK4/6-mediated phosphorylation of retinoblastoma protein (pRB), leading to inhibition of cell proliferation and tumor growth. These effects are accompanied by decreased levels of insulin resistance and increased insulin sensitivity in diabetic patients.Formula:C25H25N3O2Purity:Min. 95%Molecular weight:399.48 g/mol




